Periodic Reporting for period 3 - BRCA-ERC (Understanding cancer development in BRCA 1/2 mutation carriers for improved Early detection and Risk Control)

The BRCA-ERC programme aims to better understand the factors contributing to increased risk for breast and ovarian cancer in BRCA1/2 germline mutation carriers. Tissue specific disease penetrance of the BRCA1/2 mutation remains partly understood and we aim to learn more...